While an early IL-33 response associated with suppression of viral replication may be desirable during viral infection, during vaccination this alarmin was associated with decreased viral replication and consequential mucosal IFN responses, limiting peripheral antibody responses. This evidence concerns the gene IL33 and viral infectious disease.